126
Views
55
CrossRef citations to date
0
Altmetric
Original Research

Impact and factors associated with nighttime and early morning symptoms among patients with chronic obstructive pulmonary disease

, , , , &
Pages 577-586 | Published online: 17 Mar 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (21)

Clarus Leung & Don D. Sin. (2022) Pharmacotherapy considerations for morning symptoms in chronic obstructive pulmonary disease. Expert Opinion on Pharmacotherapy 23:12, pages 1359-1362.
Read now
Samuel De Bontridder, Jean-Louis Corhay, Christel Haenebalcke, Frederic Fievet, Isabelle Etienne & Eef Vanderhelst. (2022) Correlation of symptoms and physical activity level in chronic obstructive pulmonary disease patients: results from the observational SPACE study. Acta Clinica Belgica 77:3, pages 671-678.
Read now
Florin Mihaltan, Ruxandra-Mioara Rajnoveanu, Oana Cristina Arghir, Silviu Alecu & Paraschiva A Postolache. (2021) High 24-Hour Respiratory Symptoms and Low Physical Activity in the Stable COPD Romanian Cohort of SPACE Study. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2533-2544.
Read now
Shanshan Niu, Shuangxi Wang, Xianghuai Xu & Li Yu. (2021) Is the Symptom of Cough in Chronic Obstructive Pulmonary Disease Important?. COPD: Journal of Chronic Obstructive Pulmonary Disease 18:1, pages 123-128.
Read now
Silvia Uccelli, Laura Pini, Damiano Bottone, Piera Ranieri, Nicla Orzes & Claudio Tantucci. (2020) Dyspnea During Night-Time and at Early Morning in Patients with Stable COPD is Associated with Supine Tidal Expiratory Flow Limitation. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2549-2558.
Read now
Tian Sun, Xiaoyun Li, Wei Cheng, Yating Peng, Yiyang Zhao, Cong Liu, Yuqin Zeng, Yan Chen, Shan Cai & Ping Chen. (2020) The Relationship Between Morning Symptoms and the Risk of Future Exacerbations in COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 1899-1907.
Read now
Konstantinos Kostikas, Theodoros I Vassilakopoulos, Nikos Tzanakis, Athanasios K Konstantinidis, Epameinondas N Kosmas, Spyros Papiris, Paschalis Steiropoulos, Effrosyni D Manali, Stylianos A Michaelides & Grigorios Daskos. (2020) A Real-World Observational Study Examining the Impact of Aclidinium Bromide Therapy on the Quality of Life, Symptoms, and Activity Impairment of Patients with Chronic Obstructive Pulmonary Disease: The Greek ON-AIR Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 515-526.
Read now
Patrícia Rebelo, Ana Oliveira, Cátia Paixão, Carla Valente, Lília Andrade & Alda Marques. (2020) Minimal Clinically Important Differences for Patient-Reported Outcome Measures of Cough and Sputum in Patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 201-212.
Read now
Line Hust Storgaard, Ulla Møller Weinreich & Birgitte Schantz Laursen. (2020) COPD Patients’ Experience of Long-Term Domestic Oxygen-Enriched Nasal High Flow Treatment: A Qualitative Study. COPD: Journal of Chronic Obstructive Pulmonary Disease 17:2, pages 175-183.
Read now
Nigel Cook, Jennifer Gey, Beyza Oezel, Alexander J Mackay, Chitresh Kumari, Vinay Preet Kaur, Noel Larkin, Jennifer Harte, Sara Vergara-Muro & Florian S Gutzwiller. (2019) Impact of cough and mucus on COPD patients: primary insights from an exploratory study with an Online Patient Community. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 1365-1376.
Read now
Sverre Lehmann, Thomas Ringbæk, Anders Løkke, Ludger Grote, Jan Hedner & Eva Lindberg. (2019) A randomized trial to determine the impact of indacaterol/glycopyrronium on nighttime oxygenation and symptoms in patients with moderate-to-severe COPD: the DuoSleep study. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 199-210.
Read now
Anna Muñoz, Mark Small, Robert Wood, Anna Ribera & Javier Nuevo. (2018) The impacts of morning, daytime, and nighttime symptoms on disease burden in real-world patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1557-1568.
Read now
Patrick Fischer, Volker Gross, Johannes Kroenig, Andreas Weissflog, Olaf Hildebrandt, Keywan Sohrabi & Ulrich Koehler. (2018) Description of nighttime cough epochs in patients with stable COPD GOLD II–IV. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 1071-1078.
Read now
Johannes Krönig, Olaf Hildebrandt, Andreas Weissflog, Werner Cassel, Volker Gross, Keywan Sohrabi, Patrick Fischer & Ulrich Koehler. (2017) Long-term Recording of Night-Time Respiratory Symptoms in Patients with Stable COPD II–IV. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 498-503.
Read now
Amanda R van Buul, Marise J Kasteleyn, Niels H Chavannes & Christian Taube. (2017) The association between objectively measured physical activity and morning symptoms in COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2831-2840.
Read now
Bo Ding, Mark Small, Gina Bergström & Ulf Holmgren. (2017) A cross-sectional survey of night-time symptoms and impact of sleep disturbance on symptoms and health status in patients with COPD. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 589-599.
Read now
Klaus F. Rabe. (2017) GFF MDI for the improvement of lung function in COPD – A look at the PINNACLE-1 and PINNACLE-2 data and beyond. Expert Review of Clinical Pharmacology 10:7, pages 685-698.
Read now
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Morning symptoms in COPD: a treatable yet often overlooked factor. Expert Review of Respiratory Medicine 11:4, pages 311-322.
Read now
Maria Gabriella Matera, Alessandro Sanduzzi & Mario Cazzola. (2016) Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 73-79.
Read now
Paola Rogliani, Josuel Ora, Ermanno Puxeddu & Mario Cazzola. (2016) Airflow obstruction: is it asthma or is it COPD?. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 3007-3013.
Read now
Peter Lange, Nina Skavlan Godtfredsen, Beata Olejnicka, Bo-Anders Paradis, Dan Curiac, Sjur Humerfelt, Gunilla Telg, Helene Nordahl Christensen, Magnus Alexander Bitsch, Elisabeth Wreford Andersen & Leif Bjermer. (2016) Symptoms and quality of life in patients with chronic obstructive pulmonary disease treated with aclidinium in a real-life setting. European Clinical Respiratory Journal 3:1.
Read now

Articles from other publishers (34)

O. N. Titova, N. A. Kuzubova, A. G. Kozyrev & A. A. Shumilov. (2023) Bronchodilator therapy in patients with chronic obstructive pulmonary disease: what should be considered in clinical practice when choosing a dosing regimen?. PULMONOLOGIYA 33:1, pages 44-50.
Crossref
Nicolle J. Domnik, Devin B. Phillips, Matthew D. James, Grace A. Ayoo, Sarah M. Taylor, Robin E. Scheeren, Amanda T. Di Luch, Kathryn M. Milne, Sandra G. Vincent, Amany F. Elbehairy, Sophie J. Crinion, Helen S. Driver, J. Alberto Neder & Denis E. O’Donnell. (2022) Compensatory responses to increased mechanical abnormalities in COPD during sleep. European Journal of Applied Physiology 122:3, pages 663-676.
Crossref
Yaarit Adamovich, Vaishnavi Dandavate & Gad Asher. (2022) Circadian clocks' interactions with oxygen sensing and signalling. Acta Physiologica 234:2.
Crossref
Thomas M. Siler, Claire Hohenwarter, Kuangnan Xiong, Kenneth Sciarappa, Shahin Sanjar & Sanjay Sharma. (2021) Efficacy of Nebulized Glycopyrrolate on Lung Hyperinflation in Patients with COPD. Pulmonary Therapy 7:2, pages 503-516.
Crossref
Mirfarhad Ghalehbandi, Shahrzad Khosravifar, Oldooz Aloosh, Ania Rahimi‐Golkhandan, Mahdi Abounoori, Amirmohammad Aloosh, Hale Afshar & Shaghayegh Khosravifar. (2021) The association between sleep quality, health status and disability due to breathlessness in chronic obstructive pulmonary disease patients. The Clinical Respiratory Journal 15:11, pages 1168-1174.
Crossref
Maria Montes de Oca1, Maria Victorina Lopez Varela2, Ana Maria B. Menezes3, Fernando C. Wehrmeister3, Larissa Ramirez4 & Marc Miravitlles5. (2021) Respiratory symptoms (COPD Assessment Test and modified Medical Research Council dyspnea scores) and GOLD-ABCD COPD classification: the LASSYC study. Jornal Brasileiro de Pneumologia, pages e20210156.
Crossref
Akira Takano, Hiroshi Ishigami & Akinori Ueno. (2021) Non-Contact Measurements of Electrocardiogram and Cough-Associated Electromyogram from the Neck Using In-Pillow Common Cloth Electrodes: A Proof-of-Concept Study. Sensors 21:3, pages 812.
Crossref
Nicolle J. Domnik, Matthew D. James, Robin E. Scheeren, Grace A. Ayoo, Sarah M. Taylor, Amanda T. Di Luch, Kathryn M. Milne, Sandra G. Vincent, Devin B. Phillips, Amany F. Elbehairy, Sophie J. Crinion, Helen S. Driver, J. Alberto Neder & Denis E. O’Donnell. (2021) Deterioration of Nighttime Respiratory Mechanics in COPD. Chest 159:1, pages 116-127.
Crossref
Faith S. Luyster, Juan Wang, Frank C. Sciurba & Jessica Bon. (2020) Longitudinal associations between sleep disturbance and disease severity in patients with COPD. Sleep Science and Practice 4:1.
Crossref
Despo Ierodiakonou, Izolde Bouloukaki, Maria Kampouraki, Polyvios Papadokostakis, Ioannis Poulorinakis, Irene Lampraki, Polyxeni Athanasiou, Sophia Schiza & Ioanna Tsiligianni. (2020) Subjective sleep quality is associated with disease status in COPD patients. The cross-sectional Greek UNLOCK study. Sleep and Breathing 24:4, pages 1599-1605.
Crossref
Giap Van Vu, Giang Hai Ha, Cuong Tat Nguyen, Giang Thu Vu, Hai Quang Pham, Carl A. Latkin, Bach Xuan Tran, Roger C. M. Ho & Cyrus S. H. Ho. (2020) Interventions to Improve the Quality of Life of Patients with Chronic Obstructive Pulmonary Disease: A Global Mapping During 1990–2018. International Journal of Environmental Research and Public Health 17:9, pages 3089.
Crossref
Ioanna Tsiligianni & Janwillem W. H. Kocks. (2020) Daytime symptoms of chronic obstructive pulmonary disease: a systematic review. npj Primary Care Respiratory Medicine 30:1.
Crossref
Florin Mihaltan, Yochai Adir, Adam Antczak, Konstantinos Porpodis, Vesna Radulovic, Nuno Pires, Geeuwke Jan de Vries, Andreas Horner, Samuel De Bontridder, Yunqin Chen, Anat Shavit, Silviu Alecu & Lukasz Adamek. (2019) Importance of the relationship between symptoms and self-reported physical activity level in stable COPD based on the results from the SPACE study. Respiratory Research 20:1.
Crossref
Neeraj M. Shah & Patrick B. Murphy. (2018) Chronic obstructive pulmonary disease and sleep. Current Opinion in Pulmonary Medicine 24:6, pages 561-568.
Crossref
José Luis Izquierdo, Marc Miravitlles, Cristina Esquinas, Maite Pérez, Myriam Calle, José Luis López Campos, José Miguel Rodríguez González-Moro, Ciro Casanova, Cristóbal Esteban & Pilar de Lucas. (2018) Características de los pacientes con EPOC tratados en neumología en España según grupos GOLD y fenotipos clínicos GesEPOC. Archivos de Bronconeumología 54:11, pages 559-567.
Crossref
José Luis Izquierdo, Marc Miravitlles, Cristina Esquinas, Maite Pérez, Myriam Calle, José Luis López Campos, José Miguel Rodríguez González-Moro, Ciro Casanova, Cristóbal Esteban & Pilar de Lucas. (2018) Characteristics of COPD Patients Managed in Respiratory Medicine Departments in Spain, According to GOLD Groups and GesEPOC Clinical Phenotypes. Archivos de Bronconeumología (English Edition) 54:11, pages 559-567.
Crossref
Maochun Wu, Zequan Wang, Manman Li & Kun Li. (2017) Daily Symptom Variability in Patients With Stable COPD: A Narrative Review. Western Journal of Nursing Research 40:10, pages 1543-1561.
Crossref
Barbara P. Yawn & Barry Make. (2018) Treatment of Chronic Obstructive Pulmonary Disease in the Primary Care Setting: How Can We Achieve More for Our Patients?. The American Journal of Medicine 131:9, pages 7-14.
Crossref
Karolina Krakowiak & Hannah J. Durrington. (2018) The Role of the Body Clock in Asthma and COPD: Implication for Treatment. Pulmonary Therapy 4:1, pages 29-43.
Crossref
Lynda Doward, Henrik Svedsater, Diane Whalley, Rebecca Crawford, David Leather, James Lay-Flurrie & Nick Bosanquet. (2017) Salford Lung Study in chronic obstructive pulmonary disease (SLS COPD): follow-up interviews on patient-centred outcomes. npj Primary Care Respiratory Medicine 27:1.
Crossref
Maria Comas, Christopher J. Gordon, Brian G. Oliver, Nicholas W. Stow, Gregory King, Pawan Sharma, Alaina J. Ammit, Ronald R. Grunstein & Craig L. Phillips. (2017) A circadian based inflammatory response – implications for respiratory disease and treatment. Sleep Science and Practice 1:1.
Crossref
Colin Reisner, Gregory Gottschlich, Faisal Fakih, Andras Koser, James Krainson, Luis Delacruz, Samir Arora, Gregory Feldman, Krishna Pudi, Shahid Siddiqui, Chad Orevillo, Andrea Maes, Earl St. Rose & Ubaldo Martin. (2017) 24-h bronchodilation and inspiratory capacity improvements with glycopyrrolate/formoterol fumarate via co-suspension delivery technology in COPD. Respiratory Research 18:1.
Crossref
Marc Miravitlles & Anna Ribera. (2017) Understanding the impact of symptoms on the burden of COPD. Respiratory Research 18:1.
Crossref
F. Blasi, G. W. Canonica & M. Miravitlles. (2017) Is aclidinium alone or combined with a LABA a rational choice for symptomatic COPD patients?. Respiratory Research 18:1.
Crossref
Maria Montes de Oca, Ana Menezes, Fernando C. Wehrmeister, Maria Victorina Lopez Varela, Alejandro Casas, Luis Ugalde, Alejandra Ramirez-Venegas, Laura Mendoza, Ana López, Filip Surmont & Marc Miravitlles. (2017) Adherence to inhaled therapies of COPD patients from seven Latin American countries: The LASSYC study. PLOS ONE 12:11, pages e0186777.
Crossref
Marc Miravitlles, José Luis Izquierdo, Cristina Esquinas, Maite Pérez, Myriam Calle, José Luis López-Campos, José Miguel Rodríguez González-Moro, Ciro Casanova, Cristóbal Esteban & Pilar de Lucas. (2017) The variability of respiratory symptoms and associated factors in COPD. Respiratory Medicine 129, pages 165-172.
Crossref
David M. Halpin, Alan G. Kaplan & Richard K. Russell. (2017) Why choose tiotropium for my patient? A comprehensive review of actions and outcomes versus other bronchodilators. Respiratory Medicine 128, pages 28-41.
Crossref
Bang Zheng, Canqing Yu, Liling Lin, Huaidong Du, Jun Lv, Yu Guo, Zheng Bian, Yiping Chen, Min Yu, Jianguo Li, Junshi Chen, Zhengming Chen & Liming Li. (2017) Associations of domain-specific physical activities with insomnia symptoms among 0.5 million Chinese adults. Journal of Sleep Research 26:3, pages 330-337.
Crossref
Fabiano Di Marco, Pierachille Santus, Nicola Scichilone, Paolo Solidoro, Marco Contoli, Fulvio Braido & Angelo Guido Corsico. (2017) Symptom variability and control in COPD: Advantages of dual bronchodilation therapy. Respiratory Medicine 125, pages 49-56.
Crossref
Amanda R. van Buul, Marise J. Kasteleyn, Niels H. Chavannes & Christian Taube. (2017) Association between morning symptoms and physical activity in COPD: a systematic review. European Respiratory Review 26:143, pages 160033.
Crossref
Dave Singh, Marc Miravitlles & Claus Vogelmeier. (2016) Chronic Obstructive Pulmonary Disease Individualized Therapy: Tailored Approach to Symptom Management. Advances in Therapy 34:2, pages 281-299.
Crossref
Leonardo M. Fabbri, Edward M. Kerwin, Selwyn Spangenthal, Gary T. Ferguson, Roberto Rodriguez-Roisin, James Pearle, Sanjay Sethi, Chad Orevillo, Patrick Darken, Earl St. Rose, Tracy Fischer, Michael Golden, Sarvajna Dwivedi & Colin Reisner. (2016) Dose-response to inhaled glycopyrrolate delivered with a novel Co-Suspension™ Delivery Technology metered dose inhaler (MDI) in patients with moderate-to-severe COPD. Respiratory Research 17:1.
Crossref
Dave Singh, Massimo Corradi, Monica Spinola, Stefano Petruzzelli & Alberto Papi. (2016) Extrafine beclometasone diproprionate/formoterol fumarate: a review of its effects in chronic obstructive pulmonary disease. npj Primary Care Respiratory Medicine 26:1.
Crossref
Justin Garner, Peter M. George & Elisabetta Renzoni. (2015) Cough in interstitial lung disease. Pulmonary Pharmacology & Therapeutics 35, pages 122-128.
Crossref